Archives

by in
Entry Author Date Location
Tiger Teams, Dropping Subs, and Biotech’s Elusive Second Strikes 03/03/15 National
Chimerix Drug Shows Promise As Virus Fighter for Transplant Patients 03/02/15 Raleigh Durham
Vertex Buys Spine Drug on the QT As Part of Its Post-Hep C Makeover 02/20/15 Boston
West Coast Biotech Roundup: Dendreon, Invitae, Juno, Regulus & More 02/12/15 Seattle
Gilead Exec: More Value in Quick Hep C Cure than Cancer Treatments 02/10/15 San Francisco
East Coast Biotech Roundup: Hamburg, Merck, Annovation, WaVe & More 02/09/15 Boston
J.P. Morgan 2015: Notes, Thoughts, And Conversations From the Vortex 01/16/15 National
West Coast Biotech Roundup: Hep C, 23andMe, Kite, Cash, Isis & More 01/08/15 San Francisco
Don’t Get Comfortable: 5 Biopharma Flashpoints to Consider in 2015 01/06/15 National
Hepatitis C Commercial Game Theory 01/01/15 National
West Coast Biotech Roundup: Gilead/AbbVie, Juno, Auspex, Bina & More 12/23/14 San Francisco
Enanta Pockets $75M As AbbVie, Gilead Hep C Battle Begins 12/19/14 Boston
“Innovation at Biotech’s Epicenter,” Dec. 17: Check Out the Agenda 12/10/14 San Francisco
Prescription Drug Pricing: The Fine Line Between Value and Greed 12/02/14 Boston
West Coast Biotech Roundup: Gilead, Juno, Hutch, Fibrogen & More 11/20/14 Seattle
With Gilead’s $125M Purchase, FDA Voucher Program Gains Momentum 11/19/14 San Francisco
East Coast Biotech Roundup: Regeneron, Sage, Tara, Alnylam, & More 11/14/14 Boston
East Coast Biotech Roundup: Intercept, Idera, Inotek, & More 11/07/14 Boston
Chimerix Plans $105M Stock Offering to Finance Ebola Drug Trials 10/30/14 Raleigh Durham
Chimerix Antiviral to Start in Ebola Clinical Trial 10/16/14 Raleigh Durham
What Seattle Needs (Part 3): Working Together to Revitalize Biotech 10/08/14 Seattle
Texas Ebola Patient Gets Chimerix Drug, Clinical Trials Planned 10/06/14 Raleigh Durham
Austin Biotech Savara Nets $10M to Develop Cystic Fibrosis Drug 10/06/14 Texas
What Seattle Needs (Part 1): “Semi-Successful” Biotech Companies 10/06/14 Seattle
Alios’s Corporate Venture Backers Ride RSV (And Hep C) To Big Payday 10/01/14 San Francisco
West Coast Biotech Roundup: Ebola, Immunotherapy, Avalon & More 09/26/14 San Francisco
West Coast Biotech Roundup: Halozyme, Nektar, Allozyne, Novo & More 09/18/14 Seattle
AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug 09/03/14 Boston
Coelacanths And Other IPO Thoughts Before The Autumn Markets Return 08/26/14 National
East Coast Biotech Roundup: Amicus, Accelerator, Seventh Sense, & More 08/15/14 Boston
Page 1 of 7 next page »